Doctor Xiaojun Wang
Eli Lilly & Co, Indianapolis (United States of America)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Long-acting relaxin (LY3540378) demonstrates improved renal hemodynamics response in preclinical and clinical studies
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Chronic heart failure - pharmacotherapy 6
Discovery and characterization of a long-acting relaxin analog, LY3540378, for the treatment of chronic heart failure
Event: Heart Failure 2022
Topic: Drugs, Drug Targets
Session: Heart Failure ePosters - focus on Basic Science
